Eli Lilly's Mounjaro (tirzepatide) has officially debuted in India as a new weight loss drug.Mounjaro is a once-weekly injectable that targets two hormones, GLP-1 and GIP, to manage blood sugar levels and curb cravings.The cost of Mounjaro in India is around ₹3,500 for a 2.5 mg vial and ₹4,375 for a 5 mg vial.While Mounjaro offers a promising avenue for weight management, it's important to integrate it with a balanced diet and exercise.